RETENTION OF BLINDING AT FOLLOW-UP IN A RANDOMIZED CLINICAL STUDY USING A SHAM-CONTROL CERVICAL MANIPULATION PROCEDURE FOR NECK PAIN: SECONDARY ANALYSES FROM A RANDOMIZED CLINICAL STUDY

被引:7
作者
Vernon, Howard [1 ]
Triano, John T. [2 ]
Soave, David [1 ]
Dinulos, Maricelle [1 ]
Ross, Kim [2 ]
Tran, Steven [1 ]
机构
[1] CMCC, Div Res, Toronto, ON, Canada
[2] CMCC, Toronto, ON, Canada
基金
美国国家卫生研究院;
关键词
Neck Pain; Clinical Trial; Manipulation; Spinal; Placebo; TRIALS; VALIDATION;
D O I
10.1016/j.jmpt.2013.06.005
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objective: Participants in clinical trials of spinal manipulation have not been rigorously blinded to group assignment. This study reports on secondary analyses of the retention of participant blinding beyond the immediate posttreatment time frame following a single-session, randomized clinical study. A novel control cervical manipulation procedure that has previously been shown to be therapeutically inert was contrasted with a typical manipulation procedure. Methods: A randomized clinical study of a single session of typical vs sham-control manipulation in patients with chronic neck pain was conducted. Findings of self-reported group registration at 24 to 48 hours posttreatment were computed. The Blinding Index (BI) of Bang et al was then applied to both the immediate and post-24- to 48-hour results. Results: Twenty-four to 48 hours after treatment, 94% and 22% of participants in the typical and control groups, respectively, correctly identified their group assignment. When analyzed with the BI of Bang et al, the immediate posttreatment BI for the group receiving a typical manipulation was 0.22 (95% confidence interval [CI], -0.03 to 0.47); for the group receiving a control manipulation, it was 0.19 (95% CI, -0.06 to 0.43). The BI at post-24 hours was as follows: typical = 0.75 (95% CI, 0.59-0.91) and control = -0.34 (95% CI, -0.58 to -0.11). Conclusions: This study found that the novel sham-control cervical manipulation procedure may be effective in blinding sham group allocation up to 48 hours posttreatment. It appears that, at 48 hours posttreatment, the modified form of the typical cervical manipulation was not. The sham-control procedure appears to be a promising procedure for future clinical trials.
引用
收藏
页码:522 / 526
页数:5
相关论文
共 21 条
  • [21] A phase IIa randomized clinical study testing GNbAC1, a humanized monoclonal antibody against the envelope protein of multiple sclerosis associated endogenous retrovirus in multiple sclerosis patients - A twelve month follow-up
    Derfuss, Tobias
    Curtin, Francois
    Guebelin, Claudia
    Bridel, Claire
    Rasenack, Maria
    Matthey, Alain
    Du Pasquier, Renaud
    Schluep, Myriam
    Desmeules, Jules
    Lang, Alois B.
    Perron, Herve
    Faucard, Raphael
    Porchet, Herve
    Hartung, Hans-Peter
    Kappos, Ludwig
    Lalive, Patrice H.
    JOURNAL OF NEUROIMMUNOLOGY, 2015, 285 : 68 - 70